Validated methods for assessment of subclinical atherosclerosis in rheumatology
G Kerekes, P Soltész, MT Nurmohamed… - Nature Reviews …, 2012 - nature.com
Rheumatoid arthritis, as well as other types of arthritides and connective tissue diseases, is
associated with accelerated atherosclerosis, and increased cardiovascular morbidity and …
associated with accelerated atherosclerosis, and increased cardiovascular morbidity and …
Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do
Z Szekanecz, G Kerekes, E Végh, Z Kardos… - Autoimmunity …, 2016 - Elsevier
Autoimmune-inflammatory rheumatic diseases, such as rheumatoid arthritis (RA) have been
associated with autoimmune atherosclerosis leading to increased cardiovascular risk …
associated with autoimmune atherosclerosis leading to increased cardiovascular risk …
[HTML][HTML] Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis
K Gulyás, Á Horváth, E Végh, A Pusztai… - Clinical …, 2020 - Springer
Objectives Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) have been associated
with generalized and localized bone loss. We conducted a comprehensive study using …
with generalized and localized bone loss. We conducted a comprehensive study using …
Pharmacogenetics and pharmacogenomics in rheumatology
Pharmacogenetics and pharmacogenomics deal with possible associations of a single
genetic polymorphism or those of multiple gene profiles with responses to drugs. In …
genetic polymorphism or those of multiple gene profiles with responses to drugs. In …
[HTML][HTML] Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
A Hamar, Z Szekanecz, A Pusztai, M Czókolyová… - Osteoporosis …, 2021 - Springer
Janus kinase (JAK) inhibitors are used to treat rheumatoid arthritis (RA). We assessed the
effects of tofacitinib on bone density and bone markers in association with clinical and …
effects of tofacitinib on bone density and bone markers in association with clinical and …
Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept
É Rákóczi, B Perge, E Végh, P Csomor, A Pusztai… - Joint Bone Spine, 2016 - Elsevier
Objectives To prospectively evaluate the immunogenicity of a 13-valent conjugated
pneumococcal vaccine (PCV13) in rheumatoid arthritis (RA) patients undergoing etanercept …
pneumococcal vaccine (PCV13) in rheumatoid arthritis (RA) patients undergoing etanercept …
[HTML][HTML] Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis
E Végh, G Kerekes, A Pusztai, A Hamar… - Rheumatology …, 2020 - Springer
Accelerated atherosclerosis, increased cardiovascular morbidity and mortality have been
associated with rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Vascular function …
associated with rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Vascular function …
[HTML][HTML] Salivary citrullinated proteins in rheumatoid arthritis and associated periodontal disease
Periodontal disease (PD) can be an important precipitating factor in the production of
citrullinated proteins. Its importance is emphasized, but it is not the only way to produce …
citrullinated proteins. Its importance is emphasized, but it is not the only way to produce …
Longterm effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow cytometry for more sensitive assessment …
Objective. To assess the efficacy and safety of longterm rituximab (RTX) therapy for
rheumatoid arthritis (RA) and study correlations among B cell depletion, clinical response …
rheumatoid arthritis (RA) and study correlations among B cell depletion, clinical response …
[HTML][HTML] Changes of metabolic biomarker levels upon one-year anti-TNF-α therapy in rheumatoid arthritis and ankylosing spondylitis: associations with vascular …
M Czókolyová, A Pusztai, E Végh, Á Horváth… - Biomolecules, 2021 - mdpi.com
Background: Cardiovascular (CV) morbidity, mortality, and metabolic syndrome are
associated with rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Here, lipids and …
associated with rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Here, lipids and …